Growth Hormone and DHEA for IVF in Women with Low Ovarian Reserve
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests whether adding growth hormone and DHEA to your IVF medications can help women with low ovarian reserve get more eggs and improve pregnancy chances. It may be an option if you are over 40, have had few eggs before, or have low egg count markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have at least two of these: being over 40 (or having a reason for low egg response), getting 3 or fewer eggs in a past IVF cycle, or having low ovarian reserve (low AFC or AMH).
- You do not have any hormone or metabolic condition such as high prolactin, diabetes, or thyroid problems.
- You do not have any pelvic issues like blocked fallopian tubes or an abnormal uterus shape.
- There is no male infertility factor (like very low sperm count or no sperm).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different medication approaches to help women who had a low number of eggs in a previous IVF cycle produce more eggs this time. The goal is to find a better stimulation method for women with this 'low response' pattern.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
This study tests whether adding a hormone called r-hLH to standard IVF treatment helps women aged 35 to 40 produce better eggs and improve their chances of pregnancy. It is for women who are on their first or second cycle of assisted reproduction.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
This trial is studying whether a specific fertility medication (hMG) helps improve embryo quality during IVF when you are also doing genetic testing of embryos. It may help you have better embryos for transfer.
This study tests whether etanercept, a drug that reduces inflammation, can improve the chances of having a baby in women with low ovarian reserve who are undergoing IVF. It may help by calming the immune system to create a better environment for embryo implantation.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.